Wanxia Gong, Yuling Xiao, Xuechuan Hong, Lijuan Gu, Hai Deng, Zhiquan Tian, Junzhu Wu, Mengting Guan, Dean Shuailin Chen, Yishen Liu, Qihang Ding, Yuqin Liao, Yanna Pan, Zhiyun Zhang, Xiaoxing Xiong, Disheng Lu, Meijia Gu, Qianqian Li
Journal: Journal of medicinal chemistry 2022;65(3):2225-2237
PMID: 34994554
The clinical success of cisplatin ushered in a new era of the application of metallodrugs. When it comes to practice, however, drug resistance, tumor recurrence, and drug systemic toxicity make it implausible to completely heal the patients. Herein, we successfully transform an electron acceptor [1, 2, 5]thiadiazolo[3,4-]quinoxaline into a novel second near-infrared (NIR-II) fluorophore . After PEGylation and chelation, exhibits a wavelength bathochromic shift, enhanced photothermal conversion efficiency (41.77%), and an antineoplastic effect against glioma. Its potential for in vivo tumor tracking and image-guided chemo-photothermal therapy is explored. High levels of uptake and high-resolution NIR-II imaging results are thereafter obtained. The hyperthermia effect could disrupt the lysosomal membranes, which in turn aggravate the mitochondria dysfunction, arrest the cell cycle in the G2 phase, and finally lead to cancer cell apoptosis. displays a superior biocompatibility and thus can be a potential theranostic platform to combat the growth and recurrence of tumors.
Miscellaneous:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.